Interview with Andreas Djamwari, President Director, Soho Group
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…

LKPP’s acronym refers to the National Public Procurement Agency and it is a governmental institution that was established back in 2008. LKPP’s main mandate is to reform the current procurement model in several industries, which represents a relevant percentage within the total state budget, towards a more efficient and transparent as well as reliable system.
In this sense, it has four strategic underpinnings to support its mission: regulatory, education, IT, and integrity. It creates detailed and solid procurement regulation to avoid any misunderstanding, it educates all government officials to successfully implement its procurement programs, it empowers the usage of technology in its activities, and it ensures that all the three aforementioned guidelines are aligned towards a more efficient, transparent and reliable procurement system.
Contact
Address: Jl. Epicentrum Tengah Lot 11 B, Jakarta Selatan, DKI Jakarta – 12940
Tel. (021) 299 12 450
Website: http://www.lkpp.go.id/v3/
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
After 20 years experience with Boehringer Ingelheim, what would you say are the main specificities of the Indonesian pharmaceutical industry? Indonesia differs some what from other Asian countries, starting from…
IDS Distribution is part of an Asian, globe spanning Distribution Company. How does being part of a large, regionally specialized player help IDS Distribution in Indonesia? The company’s regional presence…
Although Indonesia in the last ten years had the second highest growth in ASIA in terms of drugs’ production and consumption, the market share of research based companies has dropped…
Mensa Group is one of the leaders of the pharmaceutical industry in Indonesia. What inspired you to enter the industry and specifically why did you start your venture in the…
Which are the main transformations Dos Ni Roha has undergone in recent years? Dos Ni Roha has successfully taken advantage of its wide expertise in the Indonesian market ? based…
APL is part of Zuellig, the top Asian pharmaceutical distributor. How does being part of a large, regionally specialized player help APL here in Indonesia? Being a part of Zuellig…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here